125 related articles for article (PubMed ID: 22459415)
1. Spondylarthritis and monoclonal gammopathy.
Wendling D; Prati C; Berthelot JM; Claudepierre P; Pham T
Joint Bone Spine; 2012 May; 79(3):327-9. PubMed ID: 22459415
[No Abstract] [Full Text] [Related]
2. Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma.
Kyle RA; Rajkumar SV
JAMA Oncol; 2015 May; 1(2):174-5. PubMed ID: 26181018
[No Abstract] [Full Text] [Related]
3. Prevalence of monoclonal gammopathy of undetermined significance (MGUS) among farmers involved in open field farming and/or cattle breading in France.
Lecluse Y; Comby E; Mariotte D; Tual S; Le Mauff B; Lebailly P; Gauduchon P
Leuk Lymphoma; 2016 Jul; 57(7):1727-30. PubMed ID: 26689498
[No Abstract] [Full Text] [Related]
4. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
Stelmach-Gołdyś A; Czarkowska-Paczek B
Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415
[TBL] [Abstract][Full Text] [Related]
5. Single-nucleotide polymorphism rs1052501 associated with monoclonal gammopathy of undetermined significance and multiple myeloma.
Greenberg AJ; Lee AM; Serie DJ; McDonnell SK; Cerhan JR; Liebow M; Larson DR; Colby CL; Norman AD; Kyle RA; Kumar S; Rajkumar SV; Diasio RB; Slager SL; Vachon CM
Leukemia; 2013 Feb; 27(2):515-6. PubMed ID: 22945773
[TBL] [Abstract][Full Text] [Related]
6. [Retrospective analysis of progression to multiple myeloma or related disorders in 114 patients with monoclonal gammopathy of undetermined significance in a single institute].
Yokota S; Urasaki Y; Nakamura Y; Bessho M
Rinsho Ketsueki; 2012 Mar; 53(3):303-9. PubMed ID: 22499046
[TBL] [Abstract][Full Text] [Related]
7. Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study.
Chang SH; Luo S; O'Brian KK; Thomas TS; Colditz GA; Carlsson NP; Carson KR
Lancet Haematol; 2015 Jan; 2(1):e30-6. PubMed ID: 26034780
[TBL] [Abstract][Full Text] [Related]
8. MGUS and smoldering myeloma: the most prevalent of plasma cell dyscrasias.
Richardson PG; Laubach J; Mitsiades CS; Schlossman RL; Ghobrial IM; Munshi NC; Anderson KC
Oncology (Williston Park); 2011 Jun; 25(7):594, 596. PubMed ID: 21888257
[No Abstract] [Full Text] [Related]
9. Secondary malignancies in patients with multiple myeloma, Waldenström macroglobulinemia and monoclonal gammopathy of undetermined significance.
Castillo JJ; Gertz MA
Leuk Lymphoma; 2017 Apr; 58(4):773-780. PubMed ID: 27546465
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from nagasaki atomic bomb survivors.
Iwanaga M; Tomonaga M
Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):18-20. PubMed ID: 24461807
[TBL] [Abstract][Full Text] [Related]
12. Similar epidemiological trends of pre-neoplastic precursors and their respective lymphoid malignancies in Taiwan.
Wu SJ; Lin CT; Lin SC; Hsieh PY; Hsu CA; Chu FY; Fazi C; Ghia P; Chuang SS
Ann Hematol; 2016 Oct; 95(10):1727-9. PubMed ID: 27431581
[No Abstract] [Full Text] [Related]
13. Epidemiology of Monoclonal Gammopathy of Undetermined Significance (MGUS): The experience from the specialized registry of hematologic malignancies of Basse-Normandie (France).
Cabrera Q; Macro M; Hebert B; Cornet E; Collignon A; Troussard X
Cancer Epidemiol; 2014 Aug; 38(4):354-6. PubMed ID: 24880205
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA
Eur J Haematol Suppl; 1989; 51():70-5. PubMed ID: 2516809
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience.
Alfano G; Fontana F; Colaci E; Messerotti A; Bettelli F; Potenza L; Luppi M; Cappelli G
Transplantation; 2017 Nov; 101(11):e337-e342. PubMed ID: 28731904
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal gammopathy of undetermined significance in atomic bomb survivors: incidence and transformation to multiple myeloma.
Neriishi K; Nakashima E; Suzuki G
Br J Haematol; 2003 May; 121(3):405-10. PubMed ID: 12716362
[TBL] [Abstract][Full Text] [Related]
17. Testing and management for monoclonal gammopathy of uncertain significance and myeloma patients presenting with osteoporosis and fragility fractures.
Nador G; Ramasamy K; Panitsas F; Pratt G; Sadler R; Javaid MK
Rheumatology (Oxford); 2019 Jul; 58(7):1142-1153. PubMed ID: 31225884
[TBL] [Abstract][Full Text] [Related]
18. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Björkholm M; Landgren O; Kristinsson SY
JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal gammopathy and rheumatic diseases.
Raposo A; Peixoto D; Bogas M
Acta Reumatol Port; 2014; 39(1):12-8. PubMed ID: 24811457
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of multiple myeloma drug use in cutaneous toxicity of monoclonal gammopathy of undetermined significance.
Gordon ER; Chen C; Adeuyan O; Lapolla BA; Trager MH; Fahmy LM; Schreidah CM; Wetter DA; Geskin LJ
J Am Acad Dermatol; 2024 Jul; 91(1):129-130. PubMed ID: 38479611
[No Abstract] [Full Text] [Related]
[Next] [New Search]
